Sandoz Deferasirox (Type J) 360 mg

Sandoz Deferasirox (Type J) 360 mg tablets are designed for oral administration. This medication is commonly used to manage iron overload in certain medical conditions. It is manufactured by Sandoz Canada Incorporated.

Deferasirox is primarily used to reduce iron levels in the body, often in conditions where iron overload is a concern. It is typically prescribed for individuals who have received multiple blood transfusions or have certain types of anemia. The medication helps to chelate excess iron, facilitating its removal from the body.

Common effects of Deferasirox may include gastrointestinal issues such as nausea, vomiting, or diarrhea. Some users may also experience skin rashes or changes in liver function. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.

Deferasirox should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed guidelines to avoid potential complications. Regular monitoring of liver function and other health parameters may be recommended during treatment.

Deferasirox may interact with certain medications, including those metabolized by the liver. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare professional.